what is considered a micro dose of glp 1 Micro-dosing' GLP-1 drugs bad idea. Here's why. | Novant Health Curious about GLP-1 microdosing and

Clinical trials of GLP-1 drugs have found they can lower inflammation, decrease the risk of cardiovascular and kidney disease and may help cut cravings for alcohol and tobacco

Cardiac Inflammation : High levels of pro-inflammatory markers such as C-reactive protein (CRP) are common in obese individuals and are linked to cardiovascular diseases

Thirty-three percent of those who were not on GLP-1 medications but were told by their clinician that they were overweight or obese were very or somewhat interested in taking the medications

Current understanding is largely based on pharmacovigilance data, clinical trial secondary endpoints, case reports, and small observational studies

A central role for hepatocyte growth factor in adipose tissue angiogenesis

And that increase stems from just one medication, highlighting the outsized impact GLP-1s can have on overall health care costs